‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Global Medical Office Dialogues
The benefit of SGLT2 Inhibitors in kidney disease patients with Michael Anger, MD
30
00:00:00
/ 00:14:49
30